ArticleJournal of veterinary internal medicine2020
ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.
Article in Journal of veterinary internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
154 citing papers in PubMed, 276 citations in OpenAlex.
- Prognostic interaction between clinical stage and left atrial remodeling in dogs with myxomatous mitral valve disease.The veterinary quarterly · 2026Article
- Idiopathic cholesterol pericarditis in a dog presenting with cardiac tamponade.Journal of veterinary internal medicine · 2026Article
- Evaluation of renal microvascular perfusion in dogs with cardiac disease using Superb Microvascular Imaging.Journal of veterinary internal medicine · 2026Article
- Mitral Valve Dysplasia Leading to Congestive Heart Failure in a Male Squirrel Monkey (Animals : an open access journal from MDPI · 2026Article
- Diffuse alveolar damage, acute respiratory distress syndrome (ARDS), and non-cardiogenic pulmonary edema (NCPE). Part 2: NCPE apart from ARDS, molecular and cellular consequences of primary injury to the lung interstitium, with comparative immunology of the dog and cat.Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2026Review
- Associations of C-reactive protein and neutrophil-to-lymphocyte ratio with cardiac remodeling, pulmonary hypertension, and survival outcomes in dogs with myxomatous mitral valve disease.Veterinary world · 2026Article
- Long-term follow-up of bronchomalacia after bronchoscopy: survival and prognostic factors in dogs.Journal of veterinary internal medicine · 2026Article
- Population Pharmacokinetics of Sildenafil in Dogs With Naturally Occurring Pulmonary Hypertension.Journal of veterinary pharmacology and therapeutics · 2026Article
- Right and left heart morphology and function in dogs with compensated chronic right ventricular pressure overload secondary to pulmonic stenosis or precapillary pulmonary hypertension.The Canadian veterinary journal = La revue veterinaire canadienne · 2026Article
- Successful Management of Recurrent Hemoptysis, Polycythemia and Respiratory Distress in a Dog.Animals : an open access journal from MDPI · 2026Article
- One Health Insights into Pulmonary Hypertension: Bridging Human and Canine Medicine.Veterinary sciences · 2026Review
- Echocardiographic evaluation of pulmonary vascular resistance in 459 dogs with Doppler-derived pulmonary hypertension.Journal of veterinary internal medicine · 2026Article
- Pulmonary vein stenosis due to pulmonary lymphoma in a cat.The Journal of veterinary medical science · 2026Article
- Development and evaluation of a composite echocardiographic score for predicting pulmonary hypertension severity in dogs.Journal of veterinary internal medicine · 2026Article
- When to consider mitral valve surgery in dogs: a comparative review of open mitral valve repair and transcatheter edge-to-edge repair with a proposed selection framework.Frontiers in veterinary science · 2026Review
- Case Report: Anesthetic management of two dogs with third-degree atrioventricular block undergoing elective non-cardiac surgery under temporary transvenous pacing.Frontiers in veterinary science · 2026Article
- Case Report: Anaesthetic management in a canine patient with severe atrioventricular septal defect and pulmonary hypertension undergoing non-cardiac surgery.Frontiers in veterinary science · 2026Article
- Prognostic Value of Body Weight-Independent Tricuspid Annular Plane Systolic Excursion to Systolic Pulmonary Arterial Pressure Ratio in Canine Precapillary Pulmonary Hypertension: A Retrospective Study.Animals : an open access journal from MDPI · 2025Article
- The long-term outcome and changes in tricuspid regurgitation pressure gradient in dogs diagnosed with pulmonary hypertension and Angiostrongylus vasorum infestation.The Journal of small animal practice · 2025Article
- Concurrent incomplete atrioventricular septal defect and supravalvular mitral stenosis causing heart failure in a 13-year-old cat: a case report.The Journal of veterinary medical science · 2025Article
94 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 10 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary hypertension (PH), defined by increased pressure within the pulmonary vasculature, is a hemodynamic and pathophysiologic state present in a wide variety of cardiovascular, respiratory, and systemic diseases. The purpose of this consensus statement is to provide a multidisciplinary approach to guidelines for the diagnosis, classification, treatment, and monitoring of PH in dogs. Comprehensive evaluation including consideration of signalment, clinical signs, echocardiographic parameters, and results of other diagnostic tests supports the diagnosis of PH and allows identification of associated underlying conditions. Dogs with PH can be classified into the following 6 groups: group 1, pulmonary arterial hypertension; group 2, left heart disease; group 3, respiratory disease/hypoxia; group 4, pulmonary emboli/pulmonary thrombi/pulmonary thromboemboli; group 5, parasitic disease (Dirofilaria and Angiostrongylus); and group 6, disorders that are multifactorial or with unclear mechanisms. The approach to treatment of PH focuses on strategies to decrease the risk of progression, complications, or both, recommendations to target underlying diseases or factors contributing to PH, and PH-specific treatments. Dogs with PH should be monitored for improvement, static condition, or progression, and any identified underlying disorder should be addressed and monitored simultaneously.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.